ライフサイエンスコーパス: enhanced survival

1 ncreased expression of DNMT1 and DNMT3b, and enhanced survival.

2 GFP dramatically suppressed tumor growth and enhanced survival.

3 into normal or RAG1-deficient mice displayed enhanced survival.

4 nd decreased proliferation, whereas SPRY4 KD enhanced survival.

5 pe, reduced tumor burden and metastasis, and enhanced survival.

6 engineered to overexpress MYD88 L265P showed enhanced survival.

7 se proximity of engrafted leukemic cells and enhanced survival.

8 tosis, activation of antitumor immunity, and enhanced survival.

9 g complex formation and caspase activity and enhanced survival.

10 ction led to decreased lung viral titers and enhanced survival.

11 ylated Pkn14 may explain why tan cells enjoy enhanced survival.

12 matologic parameters, splenic histology, and enhanced survival.

13 ry for the previously observed IL-7-mediated enhanced survival.

14 and functions of variant proteins related to enhanced survival.

15 impairment in other core clock genes exhibit enhanced survival.

16 ed postoperative renal function and possibly enhanced survival.

17 ither inhibitor alone (P < .001) and further enhanced survival.

18 f the alternative NF-kappaB pathway for BAFF-enhanced survival.

19 levels in DP thymocytes, resulting in their enhanced survival.

20 O(+) cells was significantly associated with enhanced survival.

21 ioether linked vaccine construct resulted in enhanced survival.

22 ol size during peak inflammation rather than enhanced survival.

23 reased surface expression of FcepsilonRI and enhanced survival.

24 rate neutrophil recruitment, activation, and enhanced survival.

25 sozyme conferred resistance to infection and enhanced survival.

26 ecreased alveolar-capillary protein leak and enhanced survival.

27 esponse parameters that could translate into enhanced survival.

28 were reached that neither caused damage nor enhanced survival.

29 appeared to be attributable predominantly to enhanced survival.

30 ocytic and DC infiltration of the tumors and enhanced survival.

31 the overexpression of the transgene with the enhanced survival.

32 as measured by reduction in tumor growth and enhanced survival.

33 ody irradiation improved HSC engraftment and enhanced survival.

34 dence of clinically significant CKD and with enhanced survival.

35 esulted in smaller, less invasive tumors and enhanced survival.

36 mma2) as adults exhibit reduced symptoms and enhanced survival.

37 d significantly better growth inhibition and enhanced survival.

38 temia, decreased endothelial activation, and enhanced survival.

39 enograft mouse model reduced tumour size and enhanced survival.

40 ectively enriched after chemotherapy through enhanced survival.

41 tasis, regression of established tumours and enhanced survival.

42 esulting in diminished pulmonary disease and enhanced survival.

43 lasting population of licensed NK cells with enhanced survival.

44 se to B cell receptor (BCR) crosslinking and enhanced survival.

45 th 100 microg DNA encoding IFN-alpha1 showed enhanced survival (10/15) in comparison to mice treated

46 Overweight and obesity are associated with enhanced survival after a CRC diagnosis.

47 Furthermore, ORAI1-deficient T cells showed enhanced survival after adoptive transfer into immunocom

48 edium, increased cellular proliferation, and enhanced survival after detachment from the culture subs

49 LB/c or C57BL/6 mouse strain showed markedly enhanced survival after infection compared to adult mice

50 re, rapid cell-cycle checkpoint recovery and enhanced survival after irradiation, whereas functional

51 eously treated with IL-12 at birth displayed enhanced survival after lethal challenge with infectious

52 ancer cells and normal fibroblasts exhibited enhanced survival after multifractionated irradiation co

53 Effective relapse therapy enhanced survival after progression, translating into a

54 mismatched allogeneic marrow grafts and show enhanced survival after such transplants.

55 BT549(gal-3 wt) also exhibited enhanced survival against peroxynitrite (up to 400 micro

56 asmodium berghei ANKA erythrocytes exhibited enhanced survival and a diminished blood-brain barrier d

57 thermore, B7x(-/-) mice showed significantly enhanced survival and a memory response to tumor rechall

58 on of a contactin ligand expressed on axons, enhanced survival and additionally promoted myelination

59 ne-phosphorylates endothelial Tie-2, causing enhanced survival and cell-cell stabilization.

60 roapoptotic BH3-only protein, which leads to enhanced survival and chemoresistance of human lung canc

61 Results demonstrated significantly enhanced survival and decreased tumor burden in mice pre

62 er recruitment of CD4 cells, consistent with enhanced survival and differences in recruitment and Th1

63 n of impaired remyelination mediated through enhanced survival and differentiation of OPs in the spin

64 irus replication and at the site of disease, enhanced survival and diminished morbidity in rJ2.2-infe

65 Finally, CD70 reverse signaling enhanced survival and effector function of human NK cell

66 model of lupus, in which the pathologically enhanced survival and expansion of germinal center B cel

67 Inhibition of activins significantly enhanced survival and expansion of pancreatic epithelial

68 (+) T cells to induce GVHD resulted from the enhanced survival and expansion of those cells.

69 bPTEN/SHIP(-/-) B cells exhibit enhanced survival and express more MCL1 and less Bim.

70 -10 (IL-10) modulates EPC biology leading to enhanced survival and function after transplantation in

71 t precancerous B cells have already acquired enhanced survival and growth capabilities before transfo

72 middle-income countries are associated with enhanced survival and improved cognitive development, bu

73 4(+) or CD25(+) cells before therapy further enhanced survival and in vivo CTL activity.

74 h of CD34(+) cells, which was accompanied by enhanced survival and increased cell cycle traverse in c

75 timulated in the presence of TGF-beta showed enhanced survival and increased production of interleuki

76 ted follicles encapsulated within fibrin had enhanced survival and integration with the host tissue f

77 noparticles (MSNPs); this uptake resulted in enhanced survival and markedly reduced metastasis.

78 Furthermore, PEDF intracerebral infusion enhanced survival and maturation of newly born oligodend

79 CQ significantly enhanced survival and may augment current treatment and

80 phosphatidylinositol-3 kinase (PI3K)/Akt and enhanced survival and migration.

81 Both enhanced survival and motility are critical to metastasi

82 The end-result is enhanced survival and neuritogenesis of various types of

83 n observed in R6/2 mice, suggesting that the enhanced survival and neuroprotection might be attributa

84 h the hydrogels optimized in vitro exhibited enhanced survival and oligodendrogenic differentiation a

85 determination of risk and guide therapies to enhanced survival and patient well-being.

86 hat CSF-1/c-fms signaling may be involved in enhanced survival and possibly invasion by cervical canc

87 feration of endometrial epithelial cells and enhanced survival and proliferation of human stromal cel

88 tial therapeutic target in AML to reduce the enhanced survival and proliferation of leukemic cells, w

89 n of Wnt signaling in the transplanted HSPCs enhanced survival and proliferation of Muller-HSPC hybri

90 5, significantly expands mature NK cells via enhanced survival and proliferation.

91 liver transplants, bucillamine significantly enhanced survival and protected against hepatic injury.

92 e mouse model of sepsis led to significantly enhanced survival and reduced bacterial load in several

93 IT CMP-001 treatment of murine A20 lymphoma enhanced survival and reduced growth of both injected an

94 nt C57BL/6-scid and BALB/cByJ-scid mice also enhanced survival and reduced parasitemia, indicating th

95 tro-generated T cells to SCID or BALB/c mice enhanced survival and reduced virus titers in the lung.

96 hat the TrkB-BDNF pathway is associated with enhanced survival and resistance to chemotherapy in neur

97 ection, and persist through a combination of enhanced survival and slow homeostatic turnover.

98 ortion of CLL are dependent on NF-kappaB for enhanced survival and suggest that inhibition of NF-kapp

99 cine/Fc-OX40L therapy is capable of inducing enhanced survival and tumor elimination in the GL261 mou

100 rophil responses, resulting in variants with enhanced survival and virulence.

101 further activation of the FLT3 receptors and enhanced survival and/or decreased apoptosis in leukemia

102 tor independent survival, artemin once again enhanced survival, and by P20 it promoted survival as ef

103 enotypes, including increased proliferation, enhanced survival, and increased anchorage-independent g

104 greater activation of the PI3K/Akt pathway, enhanced survival, and increased apoptosis in response t

105 ly reduced both tumor growth and metastasis, enhanced survival, and promoted regression of both tumor

106 The enhanced survival, and thus clonal expansion, supported

107 ng in significantly reduced tumor growth and enhanced survival as compared to a Dexo vaccine formulat

108 ich gave rise to improved body condition and enhanced survival as hosts aged.

109 . aureus and found that EPS-treated mice had enhanced survival as well as reduced weight loss, system

110 afts from normal donors showed significantly enhanced survival at all graft sites compared with conju

111 A cooperating mutation that enhanced survival (BCL2) was not sufficient to complete

112 CBLB502 injected after irradiation also enhanced survival, but at lower radiation doses.

113 ion and release of GM-CSF is responsible for enhanced survival, but the mechanisms controlling cytoki

114 induced by 4-1BB that was associated with an enhanced survival capability of CD8(+) post-REP TIL when

115 ells (e.g., anchorage-independent growth and enhanced survival capability) and that this effect requi

116 of plasma cells, presumably reflecting their enhanced survival capacity in vivo.

117 expression differences may contribute to the enhanced survival capacity of the El Tor biotype in envi

118 n of survivin, cyclin D1 and FAK, leading to enhanced survival, cell-matrix adhesion and proliferatio

119 translocating protein, showed significantly enhanced survival compared to controls.

120 ti-cancer plasmid DNA provided significantly enhanced survival compared to the same plasmid DNA loade

121 ductance, higher relative water content, and enhanced survival compared to wild-type controls.

122 fected Bax(-/-) mice had delayed disease and enhanced survival compared to WT mice.

123 ) cells, and ATP-treated T(H)17 cells showed enhanced survival compared with ATP-treated T(H)1 cells,

124 (-/-) mice (B-Traf3(-/-)) display remarkably enhanced survival compared with littermate control (WT)

125 nib, LCMV-infected Prf1 (-/-) mice exhibited enhanced survival compared with mice in which alphaIFN-g

126 IP-10-neutralizing mAbs showed significantly enhanced survival compared with mice treated with contro

127 nly one of numerous CXCR2 ligands, exhibited enhanced survival compared with that of WT mice followin

128 (G12V) PDCs expressing mutant p53(V143A) had enhanced survival compared with WT PDCs transduced with

129 itabine (3 weekly, 6-mg doses) significantly enhanced survival, compared with PT-RAIT alone.

130 of neural stem cells in vitro; however, the enhanced survival correlates with increased genetic dama

131 Enhanced survival did not correlate with numbers of BAp:

132 In UT7epo cells, siRNA knock-down of DAPK2 enhanced survival due to cytokine withdrawal, and DAPK2'

133 s greatly upregulated in thymocytes that had enhanced survival due to transgenic expression of a stab

134 rast, knock-down of Hdac1 in APL mice led to enhanced survival duration of the leukemic animals.

135 itionally, neutrophils from hPR3Tg displayed enhanced survival during apoptosis compared with control

136 6 M and 10-9 M) for increased growth and for enhanced survival during incubation at nonpermissive tem

137 In WBB6F(1)-Kit(W-sh/W-sh) mice, mast cells enhanced survival during moderately severe CLP but did n

138 of the endotoxin lipopolysaccharide and show enhanced survival during subsequent mechanical ventilati

139 model) for up to 46 days, but significantly enhanced survival during sudden anaerobiosis.

140 resistance to ionizing radiation and exhibit enhanced survival following 8-10 Gy total body irradiati

141 ar transduction with Ad:IFN-beta resulted in enhanced survival following infection with HSV-1.

142 13-deficient mice demonstrated significantly enhanced survival following infection, which correlated

143 Strikingly, Il21r(-/-) mice had enhanced survival following PVM infection, and moreover,

144 administration of exogenous IFN-gamma alone enhanced survival from H5N1 influenza virus infection, a

145 transcriptional changes were associated with enhanced survival from M. luteus + E. faecalis infection

146 imals carrying orthotopic tumors, and HDACIs enhanced survival further.

147 days (P < 0.0001) and delivery in icodextrin-enhanced survival further.

148 o increased resistance to apoptotic stimuli, enhanced survival, growth advantage, and differentiation

149 with bioluminescent reporter cells provided enhanced survival, higher local retention, and extended

150 These observations coincide with enhanced survival, improved strength and decreased motor

151 IL-13 enhanced survival in 100% O(2).

152 bition of IGF2 mRNA accumulation may lead to enhanced survival in a model of HCC.

153 c JNK1/2 deletion led to tumor reduction and enhanced survival in Akt/Notch- or p53/Kras-induced ICC

154 kemic cells from Mer(high) xenografts showed enhanced survival in coculture.

155 glucosylated form of the O-antigen mediated enhanced survival in human serum and decreased complemen

156 ltafepA), inhibits MPO activity and exhibits enhanced survival in inflamed guts.

157 er therapy and induced tumor regression that enhanced survival in mice with pulmonary metastases.

158 tumor site and induced tumor regression that enhanced survival in mice with pulmonary tumors.

159 ant hepatic failure, leading to dramatically enhanced survival in mice.

160 These gene signatures were associated with enhanced survival in patients with proneural GBM.

161 were highly coexpressed and associated with enhanced survival in stage III patients; however, CXCR3

162 17 was identified as an essential factor for enhanced survival in the absence of CB2, because CCL17 x

163 BL mutants in the TF-1 cell line resulted in enhanced survival in the absence of GM-CSF.

164 s resulted in increased expression of CXCR4, enhanced survival in the absence of growth factors, and

165 ent of immunoglobulin G1 results in markedly enhanced survival in the circulation (t1/2 > 7 days), co

166 ve stress and thereby mediate quiescence and enhanced survival in the HSC compartment, a function tha

167 The EDDI model's prediction of enhanced survival in the hysteresis zone for effloresced

168 , this mutant strain exhibited significantly enhanced survival in the intracellular compartments of m

169 onses to the larvae indicated that there was enhanced survival in the KO animals and decreased surviv

170 (k2)ABCDE genes restored capsule expression, enhanced survival in the murine urinary tract, and resto

171 paraquat, and H(2)O(2) showed significantly enhanced survival in the presence of (3R,5S,7as)-(3,5-bi

172 or treated passively with mAb 20B1 exhibited enhanced survival in the sepsis model, whereas decrease

173 ed pancreatic islets may contribute to their enhanced survival in the transplant setting.

174 dition, therapeutic administration of FGF-20 enhanced survival in this model.

175 mice exhibited reduced turnover in vivo and enhanced survival in vitro, indicative of lymphoaccumula

176 Treg was induction of Bcl-x(L) resulting in enhanced survival in vitro.

177 macrophages isolated from BCL-6-/- mice show enhanced survival in vitro.

178 daptive immune response was not required for enhanced survival, it was necessary for STAg-mediated vi

179 onstrate that 8 of the 12 isolates exhibited enhanced survival levels in 1.5 mM ASN compared to level

180 2 days after H5N1 influenza virus infection enhanced survival, lowered viral titers, and reduced cli

181 Enhanced survival mediated by either poly(I:C) or CpG DN

182 ization, suppressed tumor vessel growth, and enhanced survival (metastasis model).

183 IGF-1 enhanced survival, migration, and growth of cells from b

184 a albicans, with resistance characterized by enhanced survival, more rapid fungal clearance in key pe

185 ubdominant TCD8 clonal size was due to their enhanced survival, not proliferation.

186 eutralizing anti-IL-17R antibody ablated the enhanced survival observed in IL-10(-/-) mice.

187 The enhanced survival observed in the infected EP3(-/-) mice

188 ne limits fly survival, thus confirming that enhanced survival observed in these flies is related to

189 and SLPC both express CD28, but CD28-driven enhanced survival occurred only in the LLPC.

190 ion of the PTEN lipid phosphatase results in enhanced survival of a diversity of tumors.

191 Moreover, we found that STAT3 enhanced survival of activated T-cells by up-regulating

192 neal delivery of Ad-TD-nsIL-12 significantly enhanced survival of animals with orthotopic PaCa and cu

193 Racemase-dependent production of D-alanine enhanced survival of B. anthracis during interaction wit

194 The enhanced survival of BALEos was 75% inhibited at 6 days

195 Notably, cannibalism of MSCs enhanced survival of BCCs deprived of nutrients but supp

196 Enhanced survival of Bcl-xL transgenic neutrophils incre

197 CEP1347 also enhanced survival of both rat and human neurons and inhi

198 Creatine supplementation significantly enhanced survival of C2C12 cells incubated under hyperto

199 When diluted, retail liver and meat juices enhanced survival of Campylobacter strains at low temper

200 Enhanced survival of CD4(-/-) T cells was due to decreas

201 d infection in the brain and spinal cord and enhanced survival of CD8-deficient mice.

202 Rather, inhibition of autophagy enhanced survival of cells with moderate Bcl-2 expressio

203 acetam, an FDA-approved anti-epileptic drug, enhanced survival of chemotherapy drug-treated neurons,

204 thasone, a classic synthetic glucocorticoid, enhanced survival of critically ill patients with COVID-

205 ys by E(2) leads to pulmonary metastasis via enhanced survival of detached tuberin-null cells.

206 The enhanced survival of enkephalinergic striatal neurons wa

207 nd host signaling pathways contribute to the enhanced survival of EPEC-infected host cells.

208 Thus, through enhanced survival of existing regulatory T cells, and th

209 infected Tax-expressing cells contributed to enhanced survival of exosome-recipient cells when treate

210 Melatonin significantly enhanced survival of glial cells (as revealed by glial c

211 Constitutive expression of v-Akt likewise enhanced survival of H(2)O(2)-treated NIH3T3 cells.

212 s also effective therapeutically, conferring enhanced survival of H5N1 virus-challenged mice when tre

213 injection of sRAGE and hBD-MSCs resulted in enhanced survival of hBD-MSCs and angiogenesis in PIRI-C

214 eased nuclear p16 expression correlates with enhanced survival of head and neck cancer patients (p <

215 ockade of c-Met during T cell priming led to enhanced survival of heart, but not skin, allografts ass

216 The enhanced survival of hearts from MHC class I- and class

217 Top1mt-KO liver cancers, is correlated with enhanced survival of hepatocellular carcinoma patients.

218 GABA(A) receptor activity for 5-8 d in vitro enhanced survival of hippocampal neurons, suggesting tha

219 I knockout donor tissue led to significantly enhanced survival of HR but not LR allografts.

220 The enhanced survival of infected enterocytes by molecules s

221 , including tuberculosis drugs, resulting in enhanced survival of intracellular M. tuberculosis.

222 eficient for Wwox also exhibit significantly enhanced survival of ionizing radiation and bleomycin tr

223 aks (DSBs) induced by ionizing radiation and enhanced survival of irradiated cells.

224 ructs expressing antisense mRNA, resulted in enhanced survival of KIM-2 cells.

225 anscription of host cell genes important for enhanced survival of latently infected cells.

226 These advantages translate to significantly enhanced survival of LbL-probiotics in vivo.

227 pretreated with treprostinil and forskolin, enhanced survival of lethally irradiated recipient mice.

228 ells in secondary transplant recipients, and enhanced survival of mice after discontinuation of treat

229 Administration of truncated KC significantly enhanced survival of mice lethally infected with C. albi

230 Hu-1.6/1.1 also enhanced survival of mice that developed fatal sepsis af

231 In the presence of RIG-I, the LR miRNAs enhanced survival of mouse neuroblastoma cells, which co

232 in vivo regression of leukemia and conferred enhanced survival of NSG mice.

233 Antiviral treatment with oseltamivir enhanced survival of obese mice.

234 Immunosuppression enhanced survival of OECs and FBs, but only OEC transpla

235 d loss in ERK and Akt activation by H2O2 and enhanced survival of old hepatocytes to levels similar t

236 godendrocytes and their progenitor cells, no enhanced survival of oligodendrocytes or progenitors was

237 wed an evident reduction in astrogliosis and enhanced survival of oligodendrocytes.

238 We understand this effect in terms of the enhanced survival of organisms born at sources in the fl

239 st in the absence of a mechanism for odorant-enhanced survival of OSNs.

240 ssociation between carbapenem resistance and enhanced survival of P. aeruginosa in infected murine ho

241 We found that a single injection enhanced survival of photoreceptors and improved retinal

242 e investigated whether Survivin mediates the enhanced survival of primary hematopoietic progenitor ce

243 transcriptional regulation and significantly enhanced survival of prostate cancer cell lines ABAC3 an

244 morpholino suppression of CD47 dramatically enhanced survival of random tissue flaps.

245 Enhanced survival of recipient mice was causally related

246 LEDGF enhanced survival of retinal photoreceptor cells under s

247 , memantine treatment was associated with an enhanced survival of RGCs in the inferior retina.

248 not an adverse toxic effect was indicated by enhanced survival of ribosome mutants after arsenic expo

249 LEDGF enhanced survival of RPE cells in culture when challenge

250 lay of disease onset, expansion of lifespan, enhanced survival of spinal motor neurons, and maintenan

251 TGF-beta1 also enhanced survival of TCR-stimulated CD4+CD44high T cells

252 L) expression, leading also to significantly enhanced survival of terminally differentiating erythroi

253 anism to modify bound targets and facilitate enhanced survival of the bacterium.

254 d tonic-clonic convulsions and significantly enhanced survival of the mutant mice.

255 A trend for enhanced survival of the vaccinated macaques was also ob

256 ly attenuated by MV-alpha CD38, resulting in enhanced survival of these mice compared with the contro

257 IP therapy enhanced survival of those with gross residual disease.

258 ose deprivation substantially attenuated the enhanced survival of TRAF3-deficient B cells, with a dec

259 ogenicity of TS(-) cells by anti-FasL and in enhanced survival of TS(-) clones selected for resistanc

260 -expressing effector cells that mediated the enhanced survival of tumor-bearing mice by MOv18 IgE and

261 fected females from three fly strains showed enhanced survival or fecundity associated with Wolbachia

262 p38 MAPK inhibitor (SB239063) significantly enhanced survival over an 18-week period compared with t

263 e phase of the fluctuations was initiated by enhanced survival, particularly of juveniles and fecundi

264 als by malignant cells, imbuing them with an enhanced survival phenotype.

265 formly expressing markers associated with an enhanced survival potential.

266 e-specific CD8(+) T cell response and showed enhanced survival rate and lower viral burden in the bra

267 e caused by the APAP challenge, eliciting an enhanced survival rate.

268 These slow clearance rates associate with enhanced survival rates of ring-stage parasites briefly

269 thologs of these genes in flies dramatically enhanced survival rates under hypoxia, demonstrating tha

270 ities in response to polyclonal stimulation, enhanced survival rates with elevated expression of Bcl-

271 efficiently limited infection in the CNS and enhanced survival rates.

272 Remarkably, Atg16L1(HM) mice display enhanced survival rather than susceptibility upon infect

273 n by these cells did not contribute to their enhanced survival; rather, ROS promoted their growth fac

274 -MIBG resulted in decreased tumor growth and enhanced survival relative to injection of either agent

275 Marek's disease in chickens and resulted in enhanced survival relative to two independently produced

276 a balance of both reduced proliferation and enhanced survival, the latter being proportionally great

277 hat overexpression of ng1686 does not confer enhanced survival to hydrogen peroxide on gonococci.

278 only WDR-23A display activation of SKN-1 and enhanced survival to oxidative stress, whereas animals w

279 Enhanced survival to weaning appeared to be accomplished

280 leads to decreased caspase 3/7 activity and enhanced survival under conditions of ischemic stress.

281 channel closure, glycerol accumulation, and enhanced survival under hyperosmotic stress.

282 ree mice resulted in bacterial clearance and enhanced survival upon infection.

283 e burdens (P < 0.01), and displayed markedly enhanced survival versus the wild type (WT) when treated

284 n ROR1, we report the therapeutic benefit of enhanced survival via cellular reprograming by downregul

285 revascularization and female sex, such that enhanced survival was associated with ESVi.

286 By using mice transgenic for human CD16A, enhanced survival was observed due to expression of CD16

287 rating mutations that deregulated growth and enhanced survival were associated with normal karyotypes

288 matically, resulting in tumor regression and enhanced survival when combined with alphaPD-1 in mouse

289 to hypoxia-reoxygenation insult in vitro and enhanced survival when grafted into the heart.

290 uercus stellata had overall reduced RGR, but enhanced survival when grown with grass, while survival

291 tionally, mice pretreated with 6A4 displayed enhanced survival when subjected to fentanyl above LD(50

292 Deficiency of ROCK1 also results in enhanced survival, whereas wild-type mice die rapidly in

293 f supernatants from polarized hES-RPE showed enhanced survival, which was ablated by the presence of

294 ese variables did not identify patients with enhanced survival with ICD implantation.

295 risk assessment and identifies patients with enhanced survival with ICD in a patient cohort with redu

296 ed from lethal influenza virus challenge and enhanced survival with less weight loss and faster recov

297 +) /SCLtTA/TRE-BCR-ABL mice, the combination enhanced survival with reduced leukaemia development in

298 serovar Typhimurium strains all demonstrated enhanced survival within J774A.1 cells and murine perito

299 bacterial inoculum, cylE also contributed to enhanced survival within phagocytes that was attributed

300 ore-matched patients provides diabetics with enhanced survival without any increase in perioperative